By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dendreon Corporation 

3005 First Avenue

Seattle  Washington  98121  U.S.A.
Phone: 206-256-4545 Fax: 206-256-0571



Company News
Why Ex-Dendreon (DNDN) CEO's New Startup Could Succeed Where Dendreon Failed 3/5/2015 7:14:26 AM
Valeant (VRX) Starts Chopping Dendreon (DNDN) Employees 3/3/2015 10:53:02 AM
A Peek Inside Ex-Dendreon (DNDN) CEO, Amgen (AMGN) Scientists' New Startup Alpine Immune Sciences 3/3/2015 6:41:12 AM
Juno Therapeutics (JUNO) CEO and CFO Earn Hefty Bonuses; Poaches Ex-Amgen (AMGN), Dendreon (DNDN) Scientists 2/25/2015 6:12:58 AM
With the Help of Two Amgen (AMGN) Scientists, Ex-Dendreon (DNDN) CEO Launches Stealth Next-Gen Immunotherapy Startup in Seattle 2/6/2015 6:27:16 AM
Dendreon Corporation (DNDN) Enters Into Amended Agreement With Valeant (VRX) In Connection With Court-Supervised Sales Process 2/5/2015 10:51:23 AM
Valeant (VRX) Ups Bid for Dendreon (DNDN) Assets to $400 Million After Competing Offers Come In 2/5/2015 10:24:52 AM
Dendreon Corporation (DNDN) Gets $296 Million Cash Bid From Deal-Hungry Valeant (VRX) for Provenge Assets as Bankruptcy Auction Looms 1/30/2015 5:58:13 AM
Dendreon Corporation (DNDN) Provides Update On Restructuring Process 1/28/2015 11:30:20 AM
Dendreon Corporation (DNDN) Announces Strong Commercial Start To 2015 1/14/2015 7:55:05 AM